Snowball logo
logo
1JS_logo

Shield Therapeutics plc

€0.056+€0.003  (5.66%)
Estimate
EPS
-0.01
Beta
1.717
About the company
Ticker
1JS
ISIN
GB00BYV81293
Country
United Kingdom
Sector (GICS)
Healthcare
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru (ferric maltol), a non-salt based oral therapy for patients to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, United Kingdom.

Frequently asked questions

What sector does Shield Therapeutics plc (1JS) operate in?

Shield Therapeutics plc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Shield Therapeutics plc (1JS) current stock price?

As of the latest data, Shield Therapeutics plc stock price is €0.06, with a previous close of €0.05. Shield Therapeutics plc gained €0.00 in the last trading session, representing a 5.66% increase.

What is Shield Therapeutics plc (1JS) current market capitalization?

Shield Therapeutics plc market cap is approximately 59.89 million.

What is Shield Therapeutics plc (1JS) Earnings Per Share (EPS)?

The trailing EPS is -€0.01.

Does Shield Therapeutics plc (1JS) pay dividends?

No. Shield Therapeutics plc does not pay a dividend.

What is Shield Therapeutics plc (1JS) beta (volatility) score?

Shield Therapeutics plc has a beta of 1.717, suggesting it is more volatile than the market.